Xuechao Wan

1.5k citations
27 papers · 902 indexed · h-index 17
Topics
Cancer-related molecular mechanisms research (15 papers)Circular RNAs in diseases (10 papers)MicroRNA in disease regulation (10 papers)
Partner nations
ChinaUnited StatesItaly

In The Last Decade

Xuechao Wan

26 papers receiving 887 citations

Peers

Xuechao Wan
Comparison fields: 5 of 71
  • Molecular Biology 737
  • Cancer Research 571
  • Pulmonary and Respiratory Medicine 153
  • Oncology 69
  • Epidemiology 61
Replace Chengyi Sun with:
Chengyi Sun China
Zhe Yang China
Sufang Wu China
Florence Polet Belgium
Evan R. Abt United States
Tianbo Xu China
Donghua Gu China
Guodong Xiao China
Yang‐An Wen United States
Shaowei Mo China
Xuechao Wan relative to Chengyi Sun China Chengyi Sun's profile →
Citations per field
00.5×4.2×
Chengyi Sun · 1×
Citations per year

Countries citing papers authored by Xuechao Wan

Since Specialization
Citations

This map shows the geographic impact of Xuechao Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuechao Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuechao Wan more than expected).

Fields of papers citing papers by Xuechao Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuechao Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuechao Wan. The network helps show where Xuechao Wan may publish in the future.

Co-authorship network of co-authors of Xuechao Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Xuechao Wan. A scholar is included among the top collaborators of Xuechao Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuechao Wan. Xuechao Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 7
3 13
4 36
5 17
6 73
7 15
8 13
9 3
10 90
11 22
12 27
13 126
14 52
15 31
16 31
17 1
18
MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation.
41
19 33
20 97

About Xuechao Wan

Xuechao Wan is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Genetics, having authored 27 papers that have together received 902 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (10 papers) and MicroRNA in disease regulation (10 papers). The work is most often cited by research in Cancer Research (571 citations), Molecular Biology (737 citations) and Pulmonary and Respiratory Medicine (153 citations). Xuechao Wan has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Yalong Zhang, Shu Yang, Yao Li, Hai Wu, Zhe Kong, Yao Li, Pu Zhang, Namratha Sastry, Bo Hu and Tianzhi Huang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026